NBY - Why NovaBay Pharmaceuticals Stock Is Blasting Higher | Benzinga
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) shares are trading higher Monday after the company was granted the right to commercialize Biostem Technologies' amniotic tissue allograft.
The Details:
NovaBay has received the right to commercialize the amniotic tissue allograft which is intended for use as a protective covering during the repair of ocular surfaces and functions as a protective covering during the ...